Brief: Anixa Biosciences And Molgenie Announce That Their CoOVID-19 Compounds Are Expected To Be Effective Against The Omicron Variant
07/12/2021 13:33
Dec 7 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES AND MOLGENIE ANNOUNCE THAT THEIR
COVID-19
COMPOUNDS ARE EXPECTED TO BE EFFECTIVE AGAINST THE OMICRON
VARIANT
* ANIXA BIOSCIENCES INC - COVID-19 COMPOUNDS ALSO
ANTICIPATED TO
BE EFFECTIVE AGAINST DELTA VARIANT
Source text for Eikon: ID:nPn7PnThDa
Further company coverage: ANIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine